Phytochemical Name : Salidroside

Properties Information
PhytoCAT-ID PhytoCAT-235
Phytochemical name or plant extracts Salidroside
PMID 25814002
Literature evidence In conclusion, these findings suggest that salidroside may be a promising candidate target for the prevention and treatment of human breast cancer.
IUPAC name (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol
Phytochemicals’ class or type of plant extracts Glycoside
Source of phytochemicals or plant Extracts Rhodiola rosea
Geographical availability Alaska, Albania, Altay, Amur, Austria, Bulgaria, Buryatiya, China North-Central, Chita, Czechoslovakia, East European Russia, Finland, France, Føroyar, Germany, Great Britain, Greenland, Iceland, Inner Mongolia, Ireland, Irkutsk, Italy, Japan, Kamchatka, Kazakhstan, Khabarovsk, Korea, Krasnoyarsk, Kuril Is., Labrador, Magadan, Maine, Manchuria, Mongolia, New Brunswick, New York, Newfoundland, North Carolina, North European Russi, Norway, Nova Scotia, Pennsylvania, Poland, Primorye, Québec, Romania, Sakhalin, Spain, Svalbard, Sweden, Switzerland, Tuva, Ukraine, Vermont, West Siberia, Xinjiang, Yakutskiya, Yugoslavia
Plant parts NA
Other cancers Breast cancer
Target gene or protein NA
Gene or Protein evidence NA
Target pathways MAPK pathway
IC50 19.48 μM against MCF-7
Potency In conclusion, these findings suggest that salidroside may be a promising candidate target for the prevention and treatment of human breast cancer.
Cell line/ mice model MCF-7, Female BALB/c nude mice
Additional information  We also further disclosed that salidroside treatment significantly inhibited the intracellular reactive oxygen species (ROS) formation and MAPK pathway activation, which may contribute to the inhibition of tumor growth of breast cancer and reduction of oxidative stress.
PubChem ID 159278
Additional PMIDs 20541529 25814002 31918283
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:315148-2
Safety NA